Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 35687757

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2022 Sep 1
First author
Röth A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2022 Sep 1;140(9):933-935. doi: 10.1182/blood.2022017284.
    note
    Source null
    related pmid
    36048476
    relationship
    Comment in

Authors and identifiers

  1. name
    Röth A
    type
    Author
  2. name
    Berentsen S
    type
    Author
  3. name
    Barcellini W
    type
    Author
  4. name
    D'Sa S
    type
    Author
  5. name
    Jilma B
    type
    Author
  6. name
    Michel M
    type
    Author
  7. name
    Weitz IC
    type
    Author
  8. name
    Yamaguchi M
    type
    Author
  9. name
    Nishimura JI
    type
    Author
  10. name
    Vos JMI
    type
    Author
  11. name
    Storek M
    type
    Author
  12. name
    Wong N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Röth A
    type
    Author
  2. name
    Berentsen S
    type
    Author
  3. name
    Barcellini W
    type
    Author
  4. name
    D'Sa S
    type
    Author
  5. name
    Jilma B
    type
    Author
  6. name
    Michel M
    type
    Author
  7. name
    Weitz IC
    type
    Author
  8. name
    Yamaguchi M
    type
    Author
  9. name
    Nishimura JI
    type
    Author
  10. name
    Vos JMI
    type
    Author
  11. name
    Storek M
    type
    Author
  12. name
    Wong N
    type
    Author
bibliography ids
  1. nci-bib-38a339b8fde3a6db526a7d0d
book metadata
content sha256
413b158cd86a6ff77d4db4e4f0abb371da7b3f13c60cb44179ed64f4da2be8c6
document type
citation
dois
  1. 10.1182/blood.2021014955
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:35687757
immutable id
pubmed:35687757@413b158cd86a6ff77d4db4e4f0abb371da7b3f13c60cb44179ed64f4da2be8c6
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
9
name
Blood
nlm unique id
7603509
pages
980-991
volume
140
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2022 Sep 1;140(9):933-935. doi: 10.1182/blood.2022017284.
    note
    Source null
    related pmid
    36048476
    relationship
    Comment in
outcomes validated
false
pmid
35687757
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
063612b0a46d3b380c0183e507e9a0cb1fe0ed84969f07ffca166840899f4f93
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Sep 1
precision
day
year
2022
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35687757/
title
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.

Preserved source evidence · Independent clinical review pending · Not medical advice